More than 13.5 million Americans, equivalent to over 20% of US adults who use long-term prescribed medication (including those taking injectables), in the last three months have taken steps to stretch out their medicine, either by reducing the dosage or taking it less often than prescribed, according to a survey by market research firm ICR/International Communications Research.
Even about one in 10 patients who need critical therapy that must be injected by a health professional have found ways to stretch out these often very expensive, doctor-recommended prescriptions. Overall, for injectables, the percentage of patients who indicated doing this in the last three months ranges from 9% for those administered by a health care professional, to 22% for self-injected drugs like insulin for diabetics. Issues of overall cost and the recent financial climate, including factors relating to insurance coverage and medication co-pay, were cited most often as the reasons why people have begun trying to make their prescriptions last longer.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze